Kappos L - Search Results

1

Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

Kappos L, Kuhle J, Gass A, Achtnichts L, Radue EW. Kappos L, et al. J Neurol. 2004 Sep;251 Suppl 5:v57-v64. doi: 10.1007/s00415-004-1509-6. J Neurol. 2004. PMID: 15549357 Review.

2

Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter.

Roser W, Hagberg G, Mader I, Brunnschweiler H, Radue EW, Seelig J, Kappos L. Roser W, et al. Among authors: kappos l. Magn Reson Med. 1995 Jun;33(6):811-7. doi: 10.1002/mrm.1910330611. Magn Reson Med. 1995. PMID: 7651118

3

Interferon beta in the treatment of multiple sclerosis--closing remarks.

Kappos L. Kappos L. Mult Scler. 1995;1 Suppl 1:S64-6. Mult Scler. 1995. PMID: 9345403 Review. No abstract available.

4

Combinations of drugs.

Kappos L. Kappos L. Mult Scler. 1996 Jul;1(6):400-3. doi: 10.1177/135245859600100624. Mult Scler. 1996. PMID: 9345426

5

[MRI follow-up in multiple sclerosis. A guideline for quality assurance].

Gass A, Radü EW, Filippi M, Kappos L. Gass A, et al. Among authors: kappos l. Rofo. 1999 Jun;170(6):581-6. doi: 10.1055/s-2007-1011095. Rofo. 1999. PMID: 10420909 Review. German.

6

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

Kappos L, Moeri D, Radue EW, Schoetzau A, Schweikert K, Barkhof F, Miller D, Guttmann CR, Weiner HL, Gasperini C, Filippi M. Kappos L, et al. Lancet. 1999 Mar 20;353(9157):964-9. doi: 10.1016/s0140-6736(98)03053-0. Lancet. 1999. PMID: 10459905

7

Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study.

Mader I, Roser W, Kappos L, Hagberg G, Seelig J, Radue EW, Steinbrich W. Mader I, et al. Among authors: kappos l. AJNR Am J Neuroradiol. 2000 Aug;21(7):1220-7. AJNR Am J Neuroradiol. 2000. PMID: 10954272 Free PMC article. Clinical Trial.

8

Final analysis of the European multicenter trial on IFNbeta-1b in secondary-progressive MS.

Kappos L, Polman C, Pozzilli C, Thompson A, Beckmann K, Dahlke F; European Study Group in Interferon beta-1b in Secondary-Progressive MS. Kappos L, et al. Neurology. 2001 Dec 11;57(11):1969-75. doi: 10.1212/wnl.57.11.1969. Neurology. 2001. PMID: 11739811 Clinical Trial.

9

Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.

Molyneux PD, Barker GJ, Barkhof F, Beckmann K, Dahlke F, Filippi M, Ghazi M, Hahn D, MacManus D, Polman C, Pozzilli C, Kappos L, Thompson AJ, Wagner K, Yousry T, Miller DH; European Study Group on Interferon Beta-1b in Secondary Progressive MS. Molyneux PD, et al. Among authors: kappos l. Neurology. 2001 Dec 26;57(12):2191-7. doi: 10.1212/wnl.57.12.2191. Neurology. 2001. PMID: 11756596 Clinical Trial.

10

Swallowing abnormalities in multiple sclerosis: correlation between videofluoroscopy and subjective symptoms.

Wiesner W, Wetzel SG, Kappos L, Hoshi MM, Witte U, Radue EW, Steinbrich W. Wiesner W, et al. Among authors: kappos l. Eur Radiol. 2002 Apr;12(4):789-92. doi: 10.1007/s003300101086. Epub 2001 Sep 5. Eur Radiol. 2002. PMID: 11960227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

807 results

Search Page

Filters